An additional exploration of data from familial adenomatous polyposis (FAP) and CRC patients indicated that the epigenetic silencing of RSPO2 is a progressive event that maximizes at mid-late stages in the adenoma to carcinoma sequence. The gene discussed is RSPO2; the disease is colorectal carcinoma.